Clinical trial

TSBL-Based Versus BMI-Based Biliopancreatic Limb Length in One-Anastomosis Gastric Bypass

Recruiting now · Not applicable · 1 countries · Registry ID NCT07796503

Recruiting nowNot applicableInterventional

What this study is about

This study compares two surgical techniques used during one-anastomosis gastric bypass (OAGB) surgery for patients with severe obesity. During this operation, surgeons create a bypass of part of the small intestine, and the length of this bypassed segment (called the biliopancreatic limb) affects both weight loss and the risk of nutritional side effects. In this trial, one group of patients has the limb length calculated individually based on the measured total length of their small intestine (TSBL-based method), while the other group receives a limb length based on standard body mass index (BMI) categories (BMI-based method). The study compares weight loss outcomes, improvement of obesity-related health problems, and complication rates between the two approaches over 12 months after surgery. The trial is being conducted at a single center in Almaty, Kazakhstan, and plans to enroll 100 patients total; this record reflects an interim analysis based on the first 75 patients enrolled.

A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.

Basic eligibility

Age18 Years to 65 Years

SexAll

Healthy volunteersNot accepted

ConditionMorbid Obesity, Obesity

Full registry criteria

Inclusion Criteria: * Age between 18 and 65 years * BMI ≥35 kg/m² in non-Asian populations or ≥32.5 kg/m² in Asian populations * Presence or absence of metabolic comorbidities (including type 2 diabetes, hypertension, and dyslipidaemia) * Eligibility for primary one-anastomosis gastric bypass (OAGB) * Provision of written informed consent Exclusion Criteria: * BMI below the defined thresholds * Severe decompensated cardiac, pulmonary, hepatic, or renal disease * Acute inflammatory conditions * Active gastric or duodenal ulcer * Psychiatric disorders or substance abuse * Pregnancy or breastfeeding * Active malignancy * Severe intra-abdominal adhesions due to prior surgery * Secondary obesity related to hypothalamic-pituitary-adrenal axis disorders

Treatments and study arms

TSBL-based biliopancreatic limb length determination

Procedure

Biliopancreatic limb length individualized intraoperatively based on measured total small bowel length (TSBL), calculated as BPL = 0.35 × TSBL, prior to laparoscopic one-anastomosis gastric bypass.

BMI-based biliopancreatic limb length determination

Procedure

Biliopancreatic limb length determined using standard fixed lengths based on preoperative BMI category (150 cm, 180 cm, or 200 cm), prior to laparoscopic one-anastomosis gastric bypass.

Primary outcomes

Percentage of Excess Weight Loss (%EWL)Baseline, 3 months, 6 months, and 12 months post-surgery

EWL defined as the proportion of weight loss relative to excess baseline weight, with ideal body weight defined as BMI 25 kg/m². Assessed longitudinally over time using linear mixed models.

Study locations

1 locations were listed when this page was built. The first 40 are shown.

JSC "National Scientific Center of Surgery named after A.N. Syzganov"🌐 Almaty, Kazakhstan

Open map

Nurbol OrynbassarContact

Email · Call +77474528797

Adil ShokebaevPrincipal Investigator